Wegovy tablets are FDA-approved for adults who meet at least 1 of these: BMI of 30 or higher (classified as obesity) BMI of 27 or higher plus at least 1 weight-related health condition, such as high blood pressure, type 2 diabetes, or high cholesterol Within that group, the pill may be especially worth discussing with your doctor if: You have needle anxiety or a strong preference to avoid injections
We also have daily tracking and journaling tools, including the option to chat with a real human coach at any time
The triple agonist approach is not about making a stronger version of the same drug
Eligibility criteria for non-diabetic tirzepatide use typically include a BMI of 30 kg/m or higher, or a BMI of 27 kg/m or higher with at least one weight-related health condition (such as hypertension, sleep apnea, or cardiovascular disease)
[3] Katturajan R, Evan Prince S